Harjeet Singh

Harjeet Singh

Auto-generated profile, based on publicly available information

Harjeet Singh

Post Graduate Institute of Medical Education and Research, Chandigarh, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2023 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
ACArup Choudhury
Arup Choudhury
JDJasdeep Dhillon
Jasdeep Dhillon
ASAravind Sekar
Aravind Sekar
GPGupta Pankaj
Gupta Pankaj
HSHarjeet Singh
Harjeet Singh
VSVishal Sharma
Vishal Sharma
Gastrointestinal Tuberculosis (GITB) and Crohn’s disease (CD) are both chronic granulomatous diseases with a predilection to involve primarily the terminal ileum. GITB is often considered a disease of the developing world, while CD and inflammatory bowel disease are considered a disease of the developed world. But in recent times, the epidemiology of both diseases has changed. Differentiating GITB from CD is of immense clinical importance as the management of both diseases differs. While GITB needs anti-tubercular therapy (ATT), CD needs immunosuppressive therapy. Misdiagnosis or a delay in diagnosis can lead to catastrophic consequences. Most of the clinical features, endoscopic findings, and imaging features are not pathognomonic for either of these two conditions. The definitive diagnosis of GITB can be clinched only in a fraction of cases with microbiological positivity (acid-fast bacilli, mycobacterial culture, or PCR-based tests). In most cases, the diagnosis is often based on consistent clinical, endoscopic, imaging, and histological findings. Similarly, no single finding can conclusively diagnose CD. Multiparametric-based predictive models incorporating clinical, endoscopy findings, histology, radiology, and serology have been used to differentiate GITB from CD with varied results. However, it is limited by the lack of validation studies for most such models. Many patients, especially in TB endemic regions, are initiated on a trial of ATT to see for an objective response to therapy. Early mucosal response assessed at two months is an objective marker of response to ATT. Prolonged ATT in CD is recognized to have a fibrotic effect. Therefore, early discrimination may be vital in preventing the delay in the diagnosis of CD and avoiding a complicated course.

17 April 2019 in JGH Open
Verified
Journal Article
Open access
PDF file
ABAkash Bansal
Akash Bansal
GPGupta Pankaj
Gupta Pankaj
HSHarjeet Singh
Harjeet Singh
JSJayanta Samanta
Jayanta Samanta
HMHarshal Mandavdhare
Harshal Mandavdhare
RKRakesh Kochhar
Rakesh Kochhar
Pancreatitis is one of the important medical conditions. Gastrointestinal (GI) complications of pancreatitis are important and lead to significant morbidity and mortality. Diagnosis of these complications is difficult and may require a strong clinical suspicion coupled with various imaging features. This review provides an extensive update of the whole spectrum of GI complication of pancreatitis, both acute and chronic, from inflammation, ischemia, and necrosis to obstruction, perforation, and GI fistulae. The focus is on the clinical and imaging features of this less commonly described aspect of pancreatitis.

20 September 2020 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
VSVishal Sharma
Vishal Sharma
HSHariom Soni
Hariom Soni
PKPraveen Kumar-M
Praveen Kumar-M
SDSaurabh Dawra
Saurabh Dawra
SMShubhra Mishra
Shubhra Mishra
UDUsha K. Dutta
Usha K. Dutta
We performed a meta-analysis to determine diagnostic accuracy of Xpert MTB/RIF for diagnosis of abdominal (intestinal or peritoneal) tuberculosis (TB) in various tissues (intestinal, omental/perito...

1 October 2020 in HPB
Verified
Journal Article
Closed access
KDKunal B. Deo
Kunal B. Deo
RKRahul Kumar
Rahul Kumar
GTGovinda Tiwari
Govinda Tiwari
HKHemanth Kumar
Hemanth Kumar
GVGanga R. Verma
Ganga R. Verma
HSHarjeet Singh
Harjeet Singh

14 May 2021 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
AJAnuraag Jena
Anuraag Jena
SMShubhra Mishra
Shubhra Mishra
ASAnurag Sachan
Anurag Sachan
HSHarjeet Singh
Harjeet Singh
ASAnupam Kumar Singh
Anupam Kumar Singh
VSVishal Sharma
Vishal Sharma

14 December 2020 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
SMShubhra Mishra
Shubhra Mishra
HMHarshal S Mandavdhare
Harshal S Mandavdhare
HSHarjeet Singh
Harjeet Singh
ACArup Choudhury
Arup Choudhury
JSJimil Shah
Jimil Shah
VSVishal Sharma
Vishal Sharma
To evaluate the use of a combination of antibiotics as an adjuvant therapy in acute severe ulcerative colitis (ASUC). Patients with ASUC were randomized to either infusions of placebo or intravenou...